Company Profile
Kane Biotech Inc., a biotechnology company provides the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and globally.
The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic infections.
Its wound care product portfolio includes antimicrobial wound gel, antimicrobial wound gel spray, and antimicrobial wound rinse under revyve name, as well as antimicrobial surgical hydrogel under coactiv+ name Scalp detoxifier product line under the Omni Bioceuticals brand. It also engages in developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds.
Its portfolio also includes revyve Antimicrobial Wound Rinse for use in acute and chronic wounds, DispersinB Hydrogel for use in surgical/acute wounds, and DispersinB Acne Cleanser for use in the treatment of mild to moderate acne vulgaris. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.